VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE AND HYGTIA THERAPEUTICS ENTER INTO GLOBAL STRATEGIC COLLABORATION VALUED AT OVER HKD500 MILLION TO CO-DEVELOP NOVEL BRAIN-PENETRANT NLRP3 INHIBITOR